Katalysen Ventures

Authorisation for the Board of Directors to resolve on share issues

The Meeting resolved to approve the proposal in accordance with the Board’s recommendation. The authorisation permits the Board, with or without preferential rights for existing shareholders, to resolve on the issuance of shares, warrants or convertible instruments to the extent set out in the presented proposal.

Adopted proposal:

The Board of Directors proposes that the general meeting resolve to authorize the Board, on one or more occasions until the next annual general meeting, with or without deviation from the shareholders’ preferential rights, to resolve on the issue of shares or warrants. Such issues may be made with or without provisions regarding consideration in kind, set-off, or other conditions.

The total number of shares that may be issued, or, in the case of warrants, may be added upon exercise under this authorization, shall amount to a maximum of 1,243,067, corresponding to a total maximum dilution of approximately 12 percent based on the current number of registered shares in the company. The purpose of the authorization is to enable the company to raise working capital and to carry out acquisitions of companies or business assets. To the extent the authorization is used for issues with deviation from shareholders’ preferential rights, such issues shall be carried out on market terms.

The company’s CEO shall be authorized to make such minor formal adjustments to the resolution as may be required in connection with registration with the Swedish Companies Registration Office (Bolagsverket).